Martin McGlynn
2012
In 2012, Martin McGlynn earned a total compensation of $1.2M as Chief Executive Officer at StemCells, a 29% increase compared to previous year.
Compensation breakdown
| Bonus | $202,125 |
|---|---|
| Salary | $550,000 |
| Stock Awards | $430,360 |
| Other | $50,590 |
| Total | $1,233,075 |
McGlynn received $550K in salary, accounting for 45% of the total pay in 2012.
McGlynn also received $202.1K in bonus, $430.4K in stock awards and $50.6K in other compensation.
Rankings
In 2012, Martin McGlynn's compensation ranked 5,319th out of 11,487 executives tracked by ExecPay. In other words, McGlynn earned more than 53.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,319 out of 11,487 | 54th |
Division Manufacturing | 1,868 out of 4,253 | 56th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 230 out of 624 | 63rd |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 128 out of 365 | 65th |
Industry Surgical and Medical Instruments and Apparatus | 64 out of 220 | 71st |
Source: SEC filing on April 30, 2015.
McGlynn's colleagues
We found four more compensation records of executives who worked with Martin McGlynn at StemCells in 2012.